Ischemic hepatitis is damage throughout the liver caused by an inadequate blood or oxygen supply.

Heart or respiratory failure may reduce the blood flow or oxygen supply to the liver.

People feel nauseated and vomit, and the liver may be tender and enlarged.

Doctors may do imaging tests to look for the cause.

Doctors treat the condition that is reducing blood flow to the liver.

In ischemic hepatitis, liver cells are damaged or die because the liver does not receive enough blood or oxygen.

Ischemic hepatitis differs from other types of hepatitis. Usually, “hepatitis” implies inflammation of the liver, which can have many causes, most commonly a virus (as in hepatitis A or B). However, in ischemic hepatitis, the liver is not inflamed. Rather, liver cell death (necrosis) occurs. The term hepatitis is used because technically, it refers to any disorder in which liver enzymes called aminotransferases leak from damaged liver cells into the blood.

Causes

Ischemic hepatitis develops when the liver’s requirements for blood, oxygen, or both are not being met.

Decreased blood flow throughout the body is the most common cause for such unmet needs. Blood flow may be decreased by the following:

A sudden, large decrease in blood pressure (as may be caused by massive bleeding, severe dehydration, or a severe, bodywide infection)

Decreased oxygen levels in the body, as may result from prolonged, severe respiratory disorders, can also cause ischemic hepatitis.

An increased need for oxygen and blood, as occurs during a severe bodywide infection ( sepsis), can contribute to ischemic hepatitis.

Blocked blood vessels can cause hepatic ischemia but only when both the hepatic artery and the portal vein are narrowed or blocked. Ischemia does not develop when only one of these blood vessels is narrowed or blocked because the liver receives blood from both the hepatic artery and portal vein, and the blood vessel that is not blocked continues to supply the liver with blood.

The most common cause of blocked blood vessels is a blood clot. (Blockage by a blood clot is called thrombosis.) Blood clots in the hepatic artery can have many causes, such as the following:

Tumors, certain medical procedures, or heart infections ( endocarditis) that cause emboli—clumps of material, such as a piece of fatty material or blood clot on the wall of an artery—to break off and travel through the bloodstream and become lodged in a blood vessel

Disorders that make blood more likely to clot (blood clotting disorders) can cause blockages in the hepatic artery or portal vein. These disorders may be inherited or acquired.

Symptoms

Symptoms include nausea and vomiting. The liver may be tender and enlarged. If people already have severe scarring of the liver ( cirrhosis), ischemic hepatitis can cause liver failure.

Diagnosis

Doctors suspect ischemic hepatitis when results of liver function tests (done to determine how well the liver is functioning and whether it is damaged) and/or blood clotting tests are abnormal in people who have a condition that can cause the disorder.

If doctors suspect ischemic hepatitis, they look for a cause. For example, they may do imaging tests to check for a blockage in the hepatic artery. These imaging tests include ultrasonography, magnetic resonance imaging (MRI) of blood vessels (magnetic resonance angiography), and arteriography, which involves taking x-rays after a radiopaque contrast agent (which is visible on x-rays) is injected into an artery.

Treatment

Doctors focus on treating the condition that is reducing blood flow to the liver. If blood flow can be restored, ischemic hepatitis commonly resolves.

Was This Page Helpful?

Also of Interest

Test your
knowledge

The portal vein is the blood vessel that brings blood to the liver from the intestines. Portal vein thrombosis is blockage or narrowing of the portal vein by a blood clot. Most people with portal vein thrombosis have which of the following symptoms?

MSD and the MSD Manuals

Merck and Co., Inc., Kenilworth, NJ, USA (known as MSD outside of the US and Canada) is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world. The Manual was first published in 1899 as a service to the community. The legacy of this great resource continues as the Merck Manual in the US and Canada and the MSD Manual in the remainder of the world. Learn more about our commitment to Global Medical Knowledge.